+1-902-442-0653 Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street

Technology
Investors
News & Media
About Us
Contact Us
- Contact
- Newsletter Subscribe
Store

Tag: Clinical Trial results

Webinars

Investor Webinar Update 20 October 2025

October 20, 2025

Archives

Archives

Categories

Insights (42)
Media & Interviews (3)
News Releases (124)
Social Media Policy (1)
Webinars (21)

Search

Subscribe to Our Newsletter

Download the Company Presentation

Read in Frontiers in Immunology our Published Research

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models - Frontiers- Sona Nanotech

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models.

Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics

Technology

Technology Overview

Therapies

Therapies Overview
Targeted Hyperthermia Therapy (THT)
Whitepapers & Publications
THT Vaccine Effect

Diagnostics

Diagnostics Overview

Investors

Share Information
Investor Presentation
Research Coverage
Financial Reports

Store

Your Cart
Order
Your Account
Shipping Information
Purchasing Information
Storage & Handling

News & Media

News Releases
Carman's Corner
Media Centre

About Us

Our Story
Leadership
Board of Directors
Advisory Board

Contact Us

Contact
Newsletter Subscribe

Follow Us

LinkedIn
Twitter
Youtube

© 2025 Sona Nanotech. All Rights Reserved.

Privacy Policy

Technology
Investors
News & Media
About Us
Contact Us
- Contact
- Newsletter Subscribe
Store